21
Neutrophils: Friend or Foe in tuberculosis pathogenesis? Shabaana A. Khader, PhD ASSOCIATE PROFESSOR DEPARTMENT OF MOLECULAR MICROBIOLOGY WASHINGTON UNIVERSITY IN ST.LOUIS ST. LOUIS

Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

  • Upload
    others

  • View
    9

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Neutrophils: Friend or Foe in tuberculosis pathogenesis?

Shabaana A. Khader, PhDASSOCIATE PROFESSOR

DEPARTMENT OF MOLECULAR MICROBIOLOGYWASHINGTON UNIVERSITY IN ST.LOUIS

ST. LOUIS

Page 2: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Neutrophils in TB pathogenesis: Friend or Foe?

Adapted from Craig et al, 2009

Chemokines (CXC, IL-8)Cytokines (IL-1b, TNF),LTB4

Phagocytosis,proteases,ROS, RNSCalprotectin (S100)

Vascular endothelium

Adhesion molecule upregulation

Transmigration

Alveolar Type II

IL-17

Page 3: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Neutrophils are infected with Mtb, and accumulate early in the lungs of Mtb-infected mice

Wolf et al, 2007Kang et al, 2011

Page 4: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Transient depletion of neutrophils impairs T cell activation and IFN production

Kang et al, 2011

Blomgran et al, 2011

Page 5: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Transient depletion of neutrophils impairs Mtb transport to LNs

Blomgran et al, 2011

Page 6: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Blomgran et al, 2011

Transient depletion of neutrophils does not impair overall bacterial control

Kang et al, 2011

Page 7: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Neutrophils play a protective role in early granulomas in zebrafish

Yang et al, 2012Green-neutrophil, Red-M.marinum

Page 8: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Can neutrophils kill mycobacteria

Mycobacteriastrain

Reference

No Mtb H37Rv Dennis, 1991

No Mtb H37Ra/M.bovisBCG

Aston et al, 19

No Mtb HL186T Reyes‐Ruvalcaba, 2007

No Mtb H37Rv Ramos‐Kichik,2009

No Mtb H37Rv Corleis et al, 2012

Yes Mtb H37Rv Jones et al, 1990

Yes Mtb H37Ra Majeed et al, 1998

Yes Mtb Erdman Kisich, 2002

Yes Mtb H37Rv and M.bovis BCG

Maritenau et al, 2007

Yes M.marinum Yang et al, 2012

Can neutrophils kill mycobacteria- jury is still out

Page 9: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Neutrophil-Friend?

ChemokinesCytokines

1. Mtb killing ?2. DC migration/T cell priming3. Early granuloma formation

Vascular endothelium

Page 10: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Neutrophilic responses inmice genetically susceptible to Mtb

Eruslanov et al, 2005

Page 11: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Eum et al, 2010

Neutrophils are the predominant infected phagocyte in airways of ATB patients

Page 12: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

Berry et al, 2010Bloom, et al, 2013Ottenhoff et al, 2012 etc.

Page 13: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

S100A8-expressing neutrophils are dominant within human A-TB granulomas

Gopal et al, 2013

Page 14: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

S100A8/A9 expressing neutrophils are dominant within A-TB granulomas in a NHP model of TB

Gopal et al, 2013Matilla et al, 2013

Page 15: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Serum S100A8/A9 proteins as biomarkers fordetermining disease severity in human TB

Gopal et al, 2013

Page 16: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Severity of lung inflammation levels in genetically diverse (JDO)Mtb-infected mice correlates with S100A8/A9-expressing neutrophils

Gopal et al, 2013

Page 17: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Neutrophil- Friend or Foe?

ChemokinesCytokines

1. Mtb killing ?2. DC migration/T cell priming3. Early granuloma formation

FRIEND-EARLY STAGES

Vascular endothelium1. Neutrophilic granulomas2. Inflammation and pathology3. Lung injury

FOE- UNRESTRAINED, DISEASE PROGRESSION

IL-17Host and Mtb strain dependent

Page 18: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Adapted from Craig et al, 2009

ChemokinesCytokines

proteases,ROS, RNSCalprotectin (S100)

Can HDT be used to treat neutrophilic inflammation during TB?

Vascular endothelium

Adhesion molecule upregulation

Page 19: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Gopal et al, 2013

Depletion of neutrophil or neutrophil associated products/receptors abrogates inflammation in murine models

Nouailles et al, 2014

Page 20: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Can HDT be used to treat neutrophilic inflammation (along with chemotherapy) during TB?

Drug Company Inhibits Clinical trials

Midesteine Medea Research

Elastase Phase III

Zileuton Critical Therapeutics

LTB4 Phase III(some proinfl.effects)

BAYX1005 Bayer LTB4 Phase II (modest effects)

SCH‐527123 Schering‐Plough

CXCR1/2 antagonist

Phase II (36.5 reduction)

SB‐656933 Glaxo CXCR2 antagonist

Phase I (55‐75 reduction)

BAY‐71‐9678 Bayer Elastase Phase I

FPS‐ZM1 Berislav et al.2013

RAGE experimental

Page 21: Neutrophils: Friend or Foe in tuberculosis pathogenesis? · Neutrophils in TB pathogenesis: Friend or Foe? Adapted from Craig et al, 2009 Chemokines (CXC, IL-8) Cytokines (IL-1b,

Acknowledgements

Deepak Kaushal (Tulane University)

Moises Selman (U.Mexico)

Joaquin Zuniga (U.Mexico)

Thomas Scriba (SATVI)

Willem Hanekom (SATVI)

Subash Babu (NIH‐TRC)

Tom Vogl (Muenster University)

Dan Zak (Seattle Biomed) Alan Aderem (Seattle Biomed)

Funding NIH ‐NHLBI, NIAID

Children’s Hospital of Pittsburgh

CTSI‐Pittsburgh

Washington University in St. Louis

Collaborators